Navigation Links
Estrogen linked to lowered immunity in fish
Date:6/3/2009

Exposure to estrogen reduces production of immune-related proteins in fish. This suggests that certain compounds, known as endocrine disruptors, may make fish more susceptible to disease.

The research may provide new clues for why intersex fish, fish kills and fish lesions often occur together in the Shenandoah and Potomac rivers. The tests were conducted in a lab by scientists from the U.S. Geological Survey.

The study, led by USGS genomics researcher Dr. Laura Robertson, revealed that largemouth bass injected with estrogen produced lowered levels of hepcidin, an important iron-regulating hormone in mammals that is also found in fish and amphibians. This is the first published study demonstrating control of hepcidin by estrogen in any animal.

Besides being an important iron-regulating hormone, researchers also suspect that hepcidin may act as an antimicrobial peptide in mammals, fish and frogs. Antimicrobial peptides are the first line of defense against disease-causing bacteria and some fungi and viruses in vertebrate animals.

"Our research suggests that estrogen-mimicking compounds may make fish more susceptible to disease by blocking production of hepcidin and other immune-related proteins that help protect fish against disease-causing bacteria," said Robertson.

USGS researchers Drs. Vicki Blazer and Luke Iwanowicz have previously found intersex occurring in fish in the Potomac and Shenandoah rivers. Intersex is primarily revealed in male fish that have immature female egg cells in their testes. Because other studies have shown that estrogen and estrogen-mimicking compounds can cause intersex, the co-occurrence of fish lesions, fish kills and intersex in these two rivers suggested to USGS scientists that estrogen-mimicking compounds could be involved in the fish lesions and fish kills in addition to being a possible cause of intersex traits.

That caused Robertson and her colleagues to investigate how estrogen could be affecting the immune system in these fish. The study showed that largemouth bass produced two different hepcidin proteins. Production of the first hepcidin protein was "turned down" by estrogen. Production of the second hepcidin protein by fish exposed to bacteria was blocked by estrogen. The fact that estrogen blocked production of hepcidins in fish exposed to bacteria gives more weight to the theory that estrogen or estrogen-mimicking chemicals could be making fish more susceptible to diseases, Robertson added.

Hepcidin could protect against bacterial infection in two ways. "First," said Robertson, "hepcidin could be an antimicrobial peptide that actually kills pathogens. Or it could be more complex. To live, a microbe must have iron, so when a microbe invades a person or animal, that microbe must obtain iron from its host. To 'fight' the microbe, a host can 'suck up iron' and store it in places inaccessible to the microbe. In mammals, hepcidin is a key player in how the host takes up and stores iron."

The study, Identification of centrarchid hepcidins and evidence that 17β-estradiol disrupts constitutive expression of hepcidin-1 and inducible expression of hepcidin-2 in largemouth bass (Micropterus salmoides), was just published in the journal, Fish & Shellfish Immunology. The authors are USGS scientists Laura Robertson, Luke Iwanowicz and Jamie Marie Marranca.


'/>"/>

Contact: Laura Robertson
lrobertson@usgs.gov
304-724-4579
United States Geological Survey
Source:Eurekalert

Related medicine news :

1. Estrogen May Help Mens Hearts
2. Penn State professor investigates estrogen, heart disease connection in women
3. Estrogen May Combat Marijuanas Effect on Cognition
4. New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
5. Naturally produced estrogen may protect women from Parkinsons disease
6. Estrogen found to increase growth of the most common childhood brain tumor
7. Estrogen pills can benefit women with metastatic breast cancer
8. FDA Approves Durameds Synthetic Conjugated Estrogens-A Vaginal Cream
9. Estrogen therapy could be dangerous for women with existing heart risk
10. Estrogen May Explain Why Women With Cystic Fibrosis Suffer More
11. Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology: